Bryce Longoria Email & Phone Number

New York City Metropolitan Area

I work with 15 assigned teams within the league to execute gate receipts and provide internal auditing, revenue reporting, and financial analysis. I also ensure transparency, accuracy, and compliance with league guidelines. Recent financial analysis projects include modeling the revenue impact of jersey patch sponsorships and sportsbook ventures.

Sacramento, California, United States

ESM Ventures is an early-stage venture capital investor. Provided research on potential acquisition targets for the firm’s $15M capital raise. Identified, vetted, and researched 150+ candidates. Built models, summaries, and decks, which I presented to the firm’s executives to prepare for meetings with acquisition targets, bankers, and private equity.

Remote

Conducted investor research and outreach for a $210M early-stage ESG venture capital investor. Researched 150+ Family Offices to assess capital-raising potential. I also developed new go-to-market positioning, highlighting the firm’s returns and investment philosophy focused on corporate responsibility.

Los Angeles, California, United States

As the 3rd employee for a diversified retail startup selling boutique clothing, art, and plants, I streamlined store payments by implementing Square checkout and then integrated the platform into the company’s eCommerce website to increase online sales by 50%. I also oversaw store operations, finances, and accounting, presenting ideas to the founders of.

Seattle, Washington, United States

Prepared analysis for consulting/business analytics company. Built predictive models (using ARIMA, LSTMs, in R) for tech and medical device stock performance. This resulted in adjustments in portfolio positions and contributed to increased returns. I also prepared analyses, insights, and recommendations for small business clients, resulting in double-digit.

Sacramento, California Area

I reported to the lead developers of this medical device firm with 22 patents. I tested 2 medical devices, specifically cardiac atrial fibrillation implants, to assess viability for commercialization.